VENUS REMEDIES has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Mar-18* | 3 Dec-18* | 3 Mar-19* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 932 | 691 | 864 | 25.1% | -7.3% |
Other income | Rs m | 3 | 5 | 38 | 714.4% | 1036.2% |
Turnover | Rs m | 935 | 695 | 902 | 29.7% | -3.6% |
Expenses | Rs m | 838 | 643 | 835 | 29.8% | -0.4% |
Gross profit | Rs m | 94 | 47 | -61 | -227.8% | -164.6% |
Depreciation | Rs m | 62 | 83 | 83 | 0.0% | 34.1% |
Interest | Rs m | 98 | 94 | 0 | -100.0% | -100.0% |
Profit before tax | Rs m | -62 | -125 | -105 | ||
Tax | Rs m | 32 | -6 | -1 | -103.3% | |
Profit after tax | Rs m | -94 | -119 | -104 | ||
Gross profit margin | % | 10.1 | 6.9 | -7.0 | ||
Effective tax rate | % | -50.9 | 4.4 | 1.0 | ||
Net profit margin | % | -10.0 | -17.2 | -11.6 |
To see how VENUS REMEDIES has performed over the last eight quarters, please visit here.
Over the last one year, VENUS REMEDIES share price has moved up from Rs 57.1 to Rs 27.4, registering a Loss of Rs 29.7 or around 52.0%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,132.3 (up 0.0%). Over the last one year it has moved down from 13,755.6 to 13,132.3, a gain of 623 points (down 4.5%).
Overall, the S&P BSE SENSEX is up 12.2% over the year.
At the current price of Rs 27.4, the price to book value (P/BV) ratio of VENUS REMEDIES stands at 0.1 times.
Sorry! There are no related views on news for this company/sector.
Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
More
| |
Equitymaster requests your view! Post a comment on "VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!